Literature DB >> 14753643

Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.

P Bordier1, S Garrigue, S S Barold, N Bressolles, S Lanusse, J Clémenty.   

Abstract

We describe three cases of patients with Alzheimer's disease who presented with cardiac syncope soon after initiation of a cholinesterase inhibitor therapy (donepezil). Bradyarrhythmia was documented in two patients, considered probable in one, and was presumed related to the cholinergic therapy. Pacemaker implantation seemed justified rather than donepezil cessation. More over, it permitted an increase in donepezil dosage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753643     DOI: 10.1016/s1099-5129(03)00080-1

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  12 in total

1.  Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB).

Authors:  Michael H Rosenbloom; Richard Finley; Melvin M Scheinman; Mitchell D Feldman; Bruce L Miller; Gil D Rabinovici
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

Review 2.  Collapse in the elderly: rivastigmine-induced heart block and a literature review of the pharmacology of acetylcholinesterase inhibitors used in Alzheimer's disease.

Authors:  Olushola Alonge; Fahad Mujtaba Iqbal; Elzbieta Cifonelli
Journal:  BMJ Case Rep       Date:  2018-04-17

3.  Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil.

Authors:  T Suleyman; P Tevfik; G Abdulkadir; S Ozlem
Journal:  Emerg Med J       Date:  2006-08       Impact factor: 2.740

4.  Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease.

Authors:  Philippe Bordier; Stephane Garrigue; Stephane Lanusse; Julien Margaine; Frederic Robert; Laurent Gencel; Alexia Lafitte
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Causes of syncope in patients with Alzheimer's disease treated with donepezil.

Authors:  Philippe Bordier; Stephane Lanusse; Stephane Garrigue; Charlotte Reynard; Frederic Robert; Laurent Gencel; Alexia Lafitte
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Alzheimer's disease, anesthesia and the cholinergic system.

Authors:  Mukul C Kapoor
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

7.  The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada.

Authors:  Allen R Huang; Calum J Redpath; Carl van Walraven
Journal:  BMC Neurol       Date:  2015-04-28       Impact factor: 2.474

Review 8.  Potential drug-drug interactions in Alzheimer patients with behavioral symptoms.

Authors:  Giuseppe Pasqualetti; Sara Tognini; Valeria Calsolaro; Antonio Polini; Fabio Monzani
Journal:  Clin Interv Aging       Date:  2015-09-08       Impact factor: 4.458

9.  Progress update: Pharmacological treatment of Alzheimer's disease.

Authors:  David B Hogan
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

10.  Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study.

Authors:  Laura Y Park-Wyllie; Muhammad M Mamdani; Ping Li; Sudeep S Gill; Andreas Laupacis; David N Juurlink
Journal:  PLoS Med       Date:  2009-09-29       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.